CD20-directed Cytolytic Antibody

1 marketed

This page covers all CD20-directed Cytolytic Antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting B-lymphocyte antigen CD20.

Targets

B-lymphocyte antigen CD20

Marketed (1)

Patent intelligence